Fig. 1
From: Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion

Change in retinal thickness after intravitreal bevacizumab. A 78-year-old patient presented with ischemic central retinal vein occlusion, which is shown by fluorescein angiography (a, b). He had symptoms for 6 months. Baseline visual acuity was reduced to hand movements. Optical coherence tomography shows baseline (c) and at the 6-month follow-up shows macular edema has decreased, the foveal contour has been lost due to the presence of the epiretinal membrane, and there is degeneration of the outer retinal layers. Although the macular edema resolves, the final acuity was no light perception